Inhibrx (INBX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.001% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q2 2024 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 76,000 | 0.46 | |
| ≡ | Viking Global Investors | Reduce 75.00% | 5,363,121 | 0.30 | |
| Q4 2023 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 76,000 | 0.51 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Add 7.71% | 511,627 | 0.04 | |
| Q4 2022 | |||||
| ≡ | Viking Global Investors | Add 25.13% | 1,333,333 | 0.16 | |
| Q3 2020 | |||||
| ≡ | Viking Global Investors | Buy | 5,305,866 | 0.35 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.